Immune Pharmaceuticals, Inc.

OTCPK:IMNP.Q Stock Report

Market Cap: US$402.0k

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Immune Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: IMNP.Q insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of IMNP.Q?
Owner TypeNumber of SharesOwnership Percentage
Institutions760.0000418%
Individual Insiders11,329,1196.23%
General Public170,565,96593.8%

Dilution of Shares: Insufficient data to determine if shareholders have been diluted in the past year.


Top Shareholders

Top 5 shareholders own 6.23% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
6.2%
Eric Hughes
11,271,460US$24.9k0%no data
0.031%
Daniel Kazado
57,259US$126.50%no data
0.00022%
Jeffrey Paley
400US$0.90%no data
0.00004%
Elite Fund Management Ltd
75US$0.20%no data
0%
Horizon Kinetics LLC
1US$00%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.